These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 327159)

  • 21. The stilbestrol disorders in historical perspective.
    Ulfelder H
    Cancer; 1980 Jun; 45(12):3008-11. PubMed ID: 6992969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clear cell carcinoma of the cervix and vagina in young women. A report of six cases with association of maternal stilbestrol therapy and adenosis of the vagina.
    Hill EC
    Am J Obstet Gynecol; 1973 Jun; 116(4):470-84. PubMed ID: 4709483
    [No Abstract]   [Full Text] [Related]  

  • 23. Stilboestrol and vaginal clear-cell adenocarcinoma syndrome.
    Monaghan JM; Sirisena LA
    Br Med J; 1978 Jun; 1(6127):1588-90. PubMed ID: 656822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol.
    Newbold RR; McLachlan JA
    Cancer Res; 1982 May; 42(5):2003-11. PubMed ID: 7066910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Male genitourinary abnormalities and maternal diethylstilbestrol.
    Coscrove MD; Benton B; Henderson BE
    J Urol; 1977 Feb; 117(2):220-2. PubMed ID: 833973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of exogenous female hormones on the fetus.
    Shapiro S; Slone D
    Epidemiol Rev; 1979; 1():110-23. PubMed ID: 398263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follow-up study of male and female offspring of DES-treated mothers a preliminary report.
    Bibbo M; Al-Naqeeb M; Baccarini I; Gill W; Newton M; Sleeper KM; Sonek RN; Wied GL
    J Reprod Med; 1975 Jul; 15(1):29-32. PubMed ID: 1171234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symposium on Adolescent Gynecology and Endocrinology. Part II: Secondary amenorrhea, hirsutism in adolescents and the clinical consequences of stilbestrol exposure in utero. The clinical consequences of stilbestrol exposure in utero.
    Kurman RJ
    West J Med; 1979 Dec; 131(6):526-32. PubMed ID: 545869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women.
    Herbst AL; Ulfelder H; Poskanzer DC
    N Engl J Med; 1971 Apr; 284(15):878-81. PubMed ID: 5549830
    [No Abstract]   [Full Text] [Related]  

  • 31. DES-associated clear cell adenocarcinoma of the vagina and cervix.
    Herbst AL
    Obstet Gynecol Surv; 1979 Nov; 34(11):844. PubMed ID: 523031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upper genital tract changes and pregnancy outcome in offspring exposed in utero to diethylstilbestrol.
    Kaufman RH; Adam E; Binder GL; Gerthoffer E
    Am J Obstet Gynecol; 1980 Jun; 137(3):299-308. PubMed ID: 7377249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaginal epithelial changes associated with in utero DES exposure.
    Noller KL
    Obstet Gynecol Surv; 1979 Nov; 34(11):847-8. PubMed ID: 523034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preservation of reproductive potential in diethylstilbestrol-related vaginal adenocarcinoma.
    Hudson CN; Crandon AJ; Baird PJ; Willcocks D
    Am J Obstet Gynecol; 1983 Feb; 145(3):375-77. PubMed ID: 6824026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical-vaginal adenosis after in utero exposure to synthetic estrogens.
    Sherman AI; Goldrath M; Berlin A; Vakhariya V; Banooni F; Michaels W; Goodman P; Brown S
    Obstet Gynecol; 1974 Oct; 44(4):531-45. PubMed ID: 4412373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diethylstilbestrol in pregnancy: an update.
    Kinch RA
    Can Med Assoc J; 1982 Nov; 127(9):812-3. PubMed ID: 7139494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. 1971.
    Herbst AL; Ulfelder H; Poskanzer DC; Longo LD
    Am J Obstet Gynecol; 1999 Dec; 181(6):1574-5. PubMed ID: 10601946
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects in the human of diethylstilbestrol (DES) use during pregnancy.
    Herbst AL
    Princess Takamatsu Symp; 1987; 18():67-75. PubMed ID: 3506546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The current status of the DES-exposed population.
    Herbst AL
    Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In utero exposure to diethylstilbestrol: adverse effects on the reproductive tract and reproductive performance and male and female offspring.
    Stillman RJ
    Am J Obstet Gynecol; 1982 Apr; 142(7):905-21. PubMed ID: 6121486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.